Savvy Trades and Investments

[2morrowsGains]

AMS...Orlando will be getting their second proton shortly after Hyperscan is FDA approve (IMO). The fact that it has been installed at Georgetown, and the Ackerman Cancer Center in Jacksonville, FL is next in line, tells FDA approval is not far away. This is form the cc...

"There is a commitment to get the latest and the best MEVION and that would be the new HYPERSCAN. And that has been installed at Georgetown but has not been FDA approved yet. And it's clear to us that, that is what Orlando wants, is the HYPERSCAN. So I don't think they're going to make a decision until they know the status of the HYPERSCAN upgrade for the MEVION machine."
https://finance.yahoo.com/news/edited-transcript-ams-earnings-conference-231049616.html

More on Hyperscan...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130326157
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130267075

I think AMS could get ESP to $0.15 a quarter this year based on just their one unit in Orlando. That alone makes the stock price worth min $6 IMO. Then there are the many other hospitals AMS is currently in talks with which is what makes this one SOooooooo undervalued especially when looking out a couple years.

I am a strong believer, holder, and accumulator in AMS. I think we could easily see over $20 within the next couple of year.